Gleevec 100 mg

Gleevec 100 mg tablets contain imatinib mesylate, a medication used to treat certain types of cancer. This oral tablet is manufactured by Novartis Pharmaceuticals Canada Inc.

Gleevec 100 mg tablets are primarily used in the treatment of specific types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Imatinib mesylate works by targeting certain proteins involved in cancer cell growth. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Common effects of Gleevec 100 mg tablets may include nausea, vomiting, diarrhea, and muscle cramps. Some users might experience swelling, fatigue, or skin rashes. These effects can vary from person to person and are not exhaustive.

Gleevec 100 mg tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Gleevec 100 mg tablets may interact with other medications, including those metabolized by the liver. It is advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of imatinib mesylate. Always consult a healthcare provider before combining Gleevec with other medications or supplements.